These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34790230)

  • 21. RSK2 as a key regulator in human skin cancer.
    Cho YY; Lee MH; Lee CJ; Yao K; Lee HS; Bode AM; Dong Z
    Carcinogenesis; 2012 Dec; 33(12):2529-37. PubMed ID: 22918890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.
    Perreard L; Fan C; Quackenbush JF; Mullins M; Gauthier NP; Nelson E; Mone M; Hansen H; Buys SS; Rasmussen K; Orrico AR; Dreher D; Walters R; Parker J; Hu Z; He X; Palazzo JP; Olopade OI; Szabo A; Perou CM; Bernard PS
    Breast Cancer Res; 2006; 8(2):R23. PubMed ID: 16626501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and clinicopathological value of CXCL12/SDF1 expression in breast cancer: A meta-analysis.
    Liu H; Li Z; Deng M; Liu Q; Zhang T; Guo W; Li P; Qiao W
    Clin Chim Acta; 2018 Sep; 484():72-80. PubMed ID: 29800557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature.
    Wang Y; Xue D; Li Y; Pan X; Zhang X; Kuang B; Zhou M; Li X; Xiong W; Li G; Zeng Z; Yang T
    J Cancer; 2016; 7(8):991-1001. PubMed ID: 27313790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.
    Kang S; Elf S; Lythgoe K; Hitosugi T; Taunton J; Zhou W; Xiong L; Wang D; Muller S; Fan S; Sun SY; Marcus AI; Gu TL; Polakiewicz RD; Chen ZG; Khuri FR; Shin DM; Chen J
    J Clin Invest; 2010 Apr; 120(4):1165-77. PubMed ID: 20234090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Clinical Implications of RSK1-3 in Human Breast Cancer.
    Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis.
    Jayaraj R; Raymond G; Krishnan S; Tzou KS; Baxi S; Ram MR; Govind SK; Chandramoorthy HC; Abu-Khzam FN; Shaw P
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397507
    [No Abstract]   [Full Text] [Related]  

  • 29. Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration.
    Czaplinska D; Turczyk L; Grudowska A; Mieszkowska M; Lipinska AD; Skladanowski AC; Zaczek AJ; Romanska HM; Sadej R
    Biochim Biophys Acta; 2014 Nov; 1843(11):2461-70. PubMed ID: 25014166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misunderstandings about Q and 'Cochran's Q test' in meta-analysis.
    Hoaglin DC
    Stat Med; 2016 Feb; 35(4):485-95. PubMed ID: 26303773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
    Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
    Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
    Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
    Ma Q; Guin S; Padhye SS; Zhou YQ; Zhang RW; Wang MH
    Mol Cancer; 2011 May; 10():66. PubMed ID: 21619683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
    Yan S; Jiao X; Li K; Li W; Zou H
    Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of ERK/RSK2-driven NFκB gene expression and cancer cell proliferation by kurarinone, a lavandulyl flavanone isolated from Sophora flavescens ait. roots.
    Berghe WV; De Naeyer A; Dijsselbloem N; David JP; De Keukeleire D; Haegeman G
    Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):247-61. PubMed ID: 21831037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis.
    Desnoyers A; González C; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
    Mol Diagn Ther; 2020 Apr; 24(2):143-151. PubMed ID: 32100239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma.
    Gawecka JE; Geerts D; Koster J; Caliva MJ; Sulzmaier FJ; Opoku-Ansah J; Wada RK; Bachmann AS; Ramos JW
    Int J Cancer; 2012 Oct; 131(7):1556-68. PubMed ID: 22213050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.